R Jeffrey Neitz

6PUBLICATIONS
62CO-AUTHORS
Major global burdens of diseaseBiomolecular modelling and designGene and molecular therapyCheminformatics and quantitative structure-activity relationshipsMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 17, 2026
Discovery of non-nucleoside inhibitors of the enterovirus D68 3D polymerase through crystallographic fragment and high-throughput biochemical screening.

|Jan 09, 2026
Large scale prospective evaluation of co-folding across 557 Mac1-ligand complexes and three virtual screens.

Jongbin Kim, Galen J Correy, Brendan W Hall

|Nov 19, 2025
The Mac1 ADP-ribosylhydrolase is a therapeutic target for SARS-CoV-2.

Rahul K Suryawanshi, Priyadarshini Jaishankar, Galen J Correy

|Apr 23, 2025
Structure-based discovery of highly bioavailable, covalent, broad-spectrum coronavirus MPro inhibitors with potent in vivo efficacy.

Tyler C Detomasi, Gilles Degotte, Sijie Huang

|Aug 16, 2024
The Mac1 ADP-ribosylhydrolase is a Therapeutic Target for SARS-CoV-2.

Rahul K Suryawanshi, Priyadarshini Jaishankar, Galen J Correy

|Jan 04, 2023
Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2.

Stefan Gahbauer, Galen J Correy, Marion Schuller

Pageof 1

Frequent Collaborators

6 joint publications

Adam R Renslo

5 joint publications

James S Fraser

5 joint publications

Brian K Shoichet

4 joint publications

Morgan E Diolaiti